BREVE-Solara Active Pharma Sciences states that the FDA has been modified through the FDA from the classification of the gene score in Cuddalore as “official action indicated”

June 2 (Reuters) – Solara Active Pharma Sciences Ltd:

SOLARA ACTIVE PHARMA SCIENCES LTD SAYS US INFORMED BY FDA CO ABOUT THE CLASSIFICATION OF THE MANUFACTURING SITE IN CUDDALORE AS “OFFICIAL ACTION INDICATED”

SOLARA ACTIVE PHARMA SCIENCES LTD SAYS COCLASSIFICATION OF THE CUDDALORE SITE HAS NO IMPACT ON BUSINESS CONTINUITY FOR FISCAL YEAR 21

SOLARA ACTIVE PHARMA SCIENCES LTD SAYS THAT THE COMPANY CONTINUES TO KEEP ITS ORIENTATIONS FOR CHIFFER EXERCISE 21 TO FIVE AND EBITDA Source Text for Eikon: Additional Company:

All quotes were delayed by no less than five minutes. See here for a complete list of operations and delays.

© 2020 Reuters. All rights are reserved.

Leave a Comment

Your email address will not be published. Required fields are marked *